Company / Tangible Book Value per Share
KalVista Pharmaceuticals, Inc. Tangible Book Value per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$2.24
FY2025
5-year range
$2.24 / $14.41
FY2021-FY2025
Trend
-46.1%
vs FY2024
Sector context
#138 of 209
Health Care
What the data says
At $2.24, KalVista Pharmaceuticals, Inc.'s tangible book value per share ranks #138 of 209 in the Health Care sector. Tangible Book Value per Share has declined for 4 consecutive years, from $14.41 in FY2021 to $2.24 in FY2025.
Based on SEC 10-K filings.
2.24 in FY2025 with a 5-year CAGR of -14.3%.
Declined from $4.38 to $2.24 over the past 2 years.
Health Care sector context is included.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -33.4%
- 5-Year CAGR
- -14.3%
- 10-Year CAGR
- -
Sector benchmark
#138 of 209 in Health CareTop 66% of 209This company $2.24 Sector average $119.74
▼
-98.1% below sector average
Key checks
Key Insights
- KalVista Pharmaceuticals, Inc.'s tangible book value per share has declined for 4 consecutive years.
- In FY2025, tangible book value per share decreased 46.1% year-over-year.
- Ranks #138 out of 209 companies in the Health Care sector.
- Peak tangible book value per share was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -3.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.24 | -46.1% |
| FY2024 | $4.16 | -5.0% |
| FY2023 | $4.38 | -42.2% |
| FY2022 | $7.58 | -47.4% |
| FY2021 | $14.41 | +197.3% |
| FY2020 | $4.85 | +241.1% |
| FY2019 | -$3.44 | -41.7% |
| FY2018 | -$2.43 | -179.9% |
| FY2017 | $3.04 | +138.0% |
| FY2016 | -$7.99 | +91.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026